All Stories

  1. Missed Opportunities in the Preparticipation Physical Examination for High School Athletes
  2. The Role of Gender in Publication in The Journal of Pediatrics 2015-2016: Equal Reviews, Unequal Opportunities
  3. Pediatric Decision Making Requires Both Guidance and Intervention Principles
  4. The Complexities of Ascertaining Public Preferences for Newborn Screening Policies
  5. The Ambivalence That Cannot Be Spoken
  6. It is time to revise the kidney allocation system to restore the pediatric advantage
  7. Gender Differences in the Authorship of Original Research in Pediatric Journals, 2001-2016
  8. Threading the Needle for the Tiniest Babies
  9. Attitudes and Counseling Practices of Pediatricians Regarding Youth Sports Participation and Concussion Risks
  10. Attitudes of Lay Stakeholders and Transplant Professionals About Disclosure to Living Kidney Donors in Exchanges and Chains
  11. Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study
  12. To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors
  13. Disclosing Health and Health Behavior Information between Living Donors and Their Recipients
  14. Living Kidney Donors and ESRD
  15. Ethical and Policy Issues in Newborn Screening of Children for Neurologic and Developmental Disorders
  16. Pediatric Professionals' Attitudes about Secondary Findings in Genomic Sequencing of Children
  17. Racial disparities in reaching the renal transplant waitlist: is geography as important as race?
  18. Reporting Incidental Findings in Genomic Scale Clinical Sequencing—A Clinical Laboratory Perspective
  19. Universal State Newborn Screening Programs Can Reduce Health Disparities
  20. Ethics in Living Donor Transplantation
  21. Post-operative nausea and vomiting
  22. The Moral and Legal Need to Disclose Despite a Certificate of Confidentiality
  23. Outcomes After Kidney Donation
  24. Decision making in liver transplantation-Limited application of the liver donor risk index
  25. Addressing the Ethical Challenges in Genetic Testing and Sequencing of Children
  26. Predictive Genetic Testing of Children and the Role of the Best Interest Standard: Currents in Contemporary Bioethics
  27. Teaching and Assessment of Ethics and Professionalism: A Survey of Pediatric Program Directors
  28. Young Physicians' Recall about Pediatric Training in Ethics and Professionalism and Its Practical Utility
  29. Communicating With Parents About Immunization Safety: Messages for Pediatricians in the IOM Report “The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies”
  30. Premature guidance about whole-genome sequencing
  31. Recommendations for returning genomic incidental findings? We need to talk!
  32. Mandatory Extended Searches in All Genome Sequencing
  33. The OHRP and SUPPORT
  34. Newborns and Other Children: In Defense of Differential Attitudes and Treatment
  35. Relational Autonomy as the Key to Effective Behavioral Change
  36. A Non-Paternalistic Conception of Relational Autonomy Still Needs Others
  37. Ethics and professionalism in medical physics: A survey of AAPM members
  38. Removing Financial Disincentives to Organ Donation: An Acceptable Next Step?
  39. Age Should Not Be Considered in the Allocation of Deceased Donor Kidneys
  40. Achieving Justice in Genomic Translation: Re-Thinking the Pathway to Benefit
  41. 50 Years Ago in The Journal of Pediatrics
  42. 50 Years Ago in The Journal of Pediatrics
  43. 50 Years Ago in The Journal of Pediatrics
  44. Parents: Critical Stakeholders in Expanding Newborn Screening
  45. Research Ethics Education for Community-Engaged Research: A Review and Research Agenda
  46. Engaging African-Americans about biobanks and the return of research results
  47. Biobank participation and returning research results: Perspectives from a deliberative engagement in South Side Chicago
  48. Incidental findings of therapeutic misconception in biobank-based research
  49. Newborn screening for lysosomal storage diseases: an ethical and policy analysis
  50. A re-examination of the use of ethnicity in prenatal carrier testing
  51. Newborn screening for sickle cell disease: whose reproductive benefit?
  52. Attitudes and Beliefs of Sports Medicine Providers to Sickle Cell Trait Screening of Student Athletes
  53. A pilot study to determine whether health care professionals perceive stigma in heterozygote carrier identification and disclosure decisions
  54. Are we adequately protecting vulnerable patients in longitudinal observational studies?
  55. In further defense of the American Academy of Pediatrics Committee on Bioethics “children as hematopoietic stem cell donors” statement
  56. Risk, Prognosis, and Unintended Consequences in Kidney Allocation
  57. In defense of the American Academy of Pediatrics Policy Statement-Children as Hematopoietic Stem Cell Donors
  58. Are We Ready to Expand Donation after Cardiac Death to the Newborn Population?
  59. A Pilot Study to Evaluate Knowledge and Attitudes of Illinois Pediatricians toward Newborn Screening for Sickle Cell Disease and Cystic Fibrosis
  60. Reactions of Pediatricians to Refusals of Medical Treatment for Minors
  61. Nine Key Functions for a Human Subjects Protection Program for Community-Engaged Research: Points to Consider
  62. The Challenges of Collaboration for Academic and Community Partners in a Research Partnership: Points to Consider
  63. Human Subjects Protections in Community-Engaged Research: A Research Ethics Framework
  64. Forty Years Later: The Scope of Bioethics Revisited
  65. An Ethical and Policy Analysis of Elective Transplantation for Metabolic Conditions Diagnosed by Newborn Screening
  66. Carrier detection in childhood: a need for policy reform
  67. The University of Chicago Institute for Translational Medicine
  68. The Ethics of Hematopoietic Stem Cell Donation by Minors
  69. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis
  70. Arguments against Respecting a Minor's Refusal of Efficacious Life-Saving Treatment Redux, Part II
  71. Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation
  72. CLINICAL AND ETHICAL CONSIDERATIONS IN MANAGING CARRIER DETECTION
  73. Against the Tide: Arguments against Respecting a Minor's Refusal of Efficacious Life-Saving Treatment
  74. Hypoplastic Left Heart Syndrome: A Paradigm Case for Examining Conscientious Objection in Pediatric Practice
  75. Should living organ donors receive financial incentives?
  76. Qualitative Insights Into How Pediatric Pay-for-Performance Programs Are Being Designed
  77. Pediatriciansʼ attitudes toward resuscitation in children with chronic illnesses
  78. T1205 A Systematic Review and Ethical Assessment of Clinical Trials in Ulcerative Colitis
  79. Patient, Heal Thyself: How the New Medicine Puts the Patient in Charge
  80. Fragile X screening: Attitudes of genetic health professionals
  81. Pediatricians’ Attitudes About Screening Newborns for Infectious Diseases
  82. Pediatricians are More Supportive of the Human Papillomavirus Vaccine than the General Public
  83. Paediatricians' attitudes and practices towards HPV vaccination
  84. Ethical and policy lessons to be learned from a family with inherited bone marrow failure
  85. Policy considerations in designing a fragile X population screening program
  86. Newborn Screening for Cystic Fibrosis: A Lesson in Public Health Disparities
  87. An Empirical Investigation of Physicians??? Attitudes Toward Intrasibling Kidney Donation by Minor Twins
  88. Potential Inefficiency of a Proposed Efficiency Model for Kidney Allocation
  89. M1890 Is There a Justification for the Attitudes and Practices of Hepatologists and Transplant Surgeons Regarding Transplantation in Patients with Alcoholic Liver Disease?
  90. Empirical data about women's attitudes towards a hypothetical pediatric biobank
  91. Ethical and policy issues in pediatric genetics
  92. Empirical data about women's attitudes toward a biobank focused on pregnancy outcomes
  93. The Moral Status of the Newborn and its Implications for Medical Decision Making
  94. Ethics of Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus
  95. Against Newborn Screening for Type 1 Diabetes
  96. Baby at Risk: The Uncertain Legacies of Medical Miracles for Babies, Families, and Society
  97. The participation of children in nontherapeutic diabetes research in the US
  98. METHODOLOGY MATTERS
  99. Growth Attenuation by Commission and Omission May Be Ethically Justifiable in Children With Profound Disabilities
  100. Book Review Children in Medical Research: Access versus Protection (Issues in Biomedical Ethics.) By Lainie Friedman Ross. 285 pp. New York, Oxford University Press, 2006. $74. 978-0-19-927328-7
  101. We Need a Registry of Living Kidney Donors
  102. Heterozygote Carrier Testing in High Schools Abroad: What are the Lessons for the U.S.?
  103. PRACTICES ABOUT DO NOT ATTEMPT RESUSCITATION ARE INFLUENCED BY WHAT PHYSICIANS WOULD WANT FOR THEIR OWN CHILDREN AND NOT BY THEIR SUBSPECIALTY AFFILIATION.
  104. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children
  105. Shared decision making in deceased-donor transplantation
  106. Phase I research and the meaning of direct benefit
  107. Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy
  108. Ethical Considerations Related to Pregnancy in Transplant Recipients
  109. Children in Medical Research
  110. Introduction
  111. Human Subject Protections in Pediatric Research
  112. Informed Consent in Pediatric Research
  113. Epilogue
  114. Payment in Pediatric Research
  115. Evolution of the 407 Process
  116. Clinical Asthma Trials
  117. 9 Research in Schools
  118. Minimizing Risks: Diabetes Research in Newborns
  119. Lead Abatement Research
  120. Diabetes Prediction and Prevention Research in Childhood
  121. Research not Otherwise Approvable: A Look at One 407 Protocol
  122. Access versus Protection: Minority Representation in Pediatric Research
  123. Overview of the Common Rule and Subpart D
  124. From 1966 to 2005: Balancing Protection and Access in Pediatric Research
  125. Should We Provide Healthy Children with Greater Protection in Medical Research?
  126. Phase I Research and the Meaning of ‘Prospect of Direct Benefit’
  127. In Reply: ABO-Incompatible List-Paired Exchanges Including an O Recipient Cannot be Ethically Justified
  128. Ethics of placebos in clinical asthma trials
  129. What Is Wrong with the Physician Charter on Professionalism
  130. The Ethical Limits in Expanding Living Donor Transplantation
  131. Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: Implications for policy
  132. In Defense of a Single Standard of Research Risk for all Children
  133. Response to “Intrafamilial Organ Donation Is Often an Altruistic Act” by Aaron Spital (CQ Vol 12, No 1) and “Donor Benefit Is the Key to Justified Living Organ Donation,” by Aaron Spital (CQ Vol 13, No 1): Motivation, Risk, and Benefit in Living Or...
  134. Parental Attitudes and Beliefs regarding the Genetic Testing of Children
  135. Useful Bodies: Humans in the Service of Medical Science in the Twentieth Century (review)
  136. Book Review Transplanting Human Tissue: Ethics, Policy, and Practice Edited by Stuart J. Youngner, Martha W. Anderson, and Renie Schapiro. 216 pp. New York, Oxford University Press, 2004. $42.50. 0-19-516284-6
  137. Reply
  138. Should Children and Adolescents Undergo Genetic Testing?
  139. Informed Consent in Pediatric Research
  140. Practical and Ethical Challenges to Paired Exchange Programs
  141. Restricting Living-Donor???Cadaver-Donor Exchanges to Ensure that Standard Blood Type O Wait-List Candidates Benefit
  142. Certificates of Confidentiality in Research: Rationale and Usage
  143. Certificates of Confidentiality in Research: Rationale and Usage
  144. Human Subject Protections in Genetic Research
  145. Human Subject Protections in Genetic Research
  146. Incorporating newborn screening into prenatal care
  147. Convening a 407 Panel for Research Not Otherwise Approvable: "Precursors to Diabetes in Japanese American Youth" as a Case Study
  148. Children in Medical Research: balancing protection and access: has the pendulum swung too far?
  149. Ethical issues in identifying and recruiting participants for familial genetic research
  150. Ethical Issues in Dialysis
Alan Spital, Series Editor: Do Not Resuscitate Orders and Iatrogenic Arrest During Dialysis: Should “No” Mean “No”?
  151. Prospective Psychosocial Monitoring of Living Kidney Donors Using the SF-36 Health Survey.
  152. Need for Genetic Education for Type 1 Diabetes—Reply
  153. Whether and Why Pediatric Researchers Report Race and Ethnicity
  154. Parental attitudes regarding newborn screening of PKU and DMD
  155. Professional and Personal Attitudes about Access and Confidentiality in the Genetic Testing of Children: A Pilot Study
  156. All living donors should not be treated equally
  157. Effect of family history on disclosure patterns of cystic fibrosis carrier status
  158. Lethal Language, Lethal Decisions
  159. Do healthy children deserve greater protection in medical research?
  160. From Detached Concern to Empathy: Humanizing Medical Practice (review)
  161. Minimizing Risks
  162. Solid Organ Donation between Strangers
  163. All Donations Should Not Be Treated Equally: A Response to Jeffrey Kahn's Commentary
  164. Should all living donors be treated equally?
  165. Do Genetic Relationships Create Moral Obligations in Organ Transplantation?
  166. Book ReviewsLainie Friedman Ross, .Children, Families, and Health Care Decision‐Making.Oxford: Clarendon Press, 1999. Pp. 197. $45.00 (cloth).
  167. In Defense of the Hopkins Lead Abatement Studies
  168. Prenatal Testing and Disability Rights (review)
  169. Predictive Genetic Testing for Conditions that Present in Childhood
  170. Media Appeals for Directed Altruistic Living Liver Donations: Lessons from Camilo Sandoval Ewen
  171. Donating a Second Kidney: A Tale of Family and Ethics
  172. The ethics of preadoption genetic testing
  173. Ethical issues in pediatric trials
  174. PRIMUM NON NOCERE: AVOIDING HARM TO VULNERABLE WAIT LIST CANDIDATES IN AN INDIRECT KIDNEY EXCHANGE
  175. Genetic Exceptionalism vs. Paradigm Shift: Lessons from HIV
  176. Genetic Exceptionalism vs. Paradigm Shift: Lessons from HIV
  177. Ethical and policy issues in genetic testing
  178. Transplantation Ethics (review)
  179. Behavioral Genetics: The Clash of Culture and Biology (review)
  180. The ethics of preadoption genetic testing
  181. Ethical Issues in Genetic Testing of Children
  182. Children, Families, and Health Care Decision-making: Lainie Friedman Ross, New York, Oxford University Press, 1998, 197 pages, pound30.
  183. Patient Confidentiality and the Surrogate's Right to Know
  184. ETHICAL ISSUES IN INCREASING LIVING KIDNEY DONATIONS BY EXPANDING KIDNEY PAIRED EXCHANGE PROGRAMS
  185. Inherited Susceptibility to Cancer: Clinical, Predictive, and Ethical Perspectives (review)
  186. PAIRED EXCHANGES SHOULD BE PART OF THE SOLUTION TO ABO INCOMPATIBILITY IN LIVING DONOR KIDNEY TRANSPLANTATION
  187. Benchmarks of Fairness for Health Care Reform By Norman Daniels, Donald W. Light, and Ronald L. Caplan
  188. Health Care Decisionmaking by Children Is It in Their Best Interest?
  189. Advantages and Disadvantages of Neonatal Circumcision
  190. Overriding a Patient's Refusal of Treatment after an Iatrogenic Complication
  191. Ethics of a Paired-Kidney-Exchange Program
  192. Religious Exemptions to the Immunization Statutes: Balancing Public Health and Religious Freedom
  193. Presymptomatic Testing for Genetic Disease: Ethical Considerations.• 155
  194. DISCLOSING MISATTRIBUTED PATERNITY
  195. Just Caring
  196. JUSTICE FOR CHILDREN: THE CHILD AS ORGAN DONOR
  197. Moral Grounding for the Participation of Children as Organ Donors
  198. Reporting Impaired Physicians
  199. Newborn Screening
  200. Genetic Testing of Children: Who Should Consent?
  201. Prenatal testing and newborn screening
  202. Genetic testing and screening of minors